Insulin Synthesis, Secretion, and Regulation

Insulin is the principal glucose-lowering hormone, made and released by pancreatic beta cells. It is first synthesized as a precursor, preproinsulin, then processed through proinsulin to mature insulin and stored in secretory granules. When blood glucose rises, beta cells sense it through their metabolism and release insulin in a tightly regulated, biphasic fashion, amplified by gut hormones and modulated by the nervous system.

Definition

Insulin synthesis and secretion is the process by which pancreatic beta cells produce insulin from its precursors and release it into the circulation in response to nutrient, hormonal, and neural signals, principally a rise in blood glucose.

Scope

The topic covers insulin biosynthesis and processing (preproinsulin, proinsulin, C-peptide, mature insulin), the mechanism of glucose-stimulated insulin secretion including the triggering and amplifying pathways, the biphasic pattern of release, and the hormonal and neural regulators of secretion such as the incretins. It is a reference-educational account of normal beta-cell physiology and does not give clinical or dosing guidance.

Core questions

• How is insulin synthesized and processed from preproinsulin to the mature hormone?
• How do beta cells sense glucose and convert that signal into insulin release?
• What distinguishes the triggering pathway from the amplifying pathway of secretion?
• Why is insulin secretion biphasic, and what does that pattern reflect?
• How do incretin hormones and the nervous system modulate insulin secretion?

Key concepts

• Preproinsulin and proinsulin
• C-peptide
• ATP-sensitive potassium channels
• Glucose-stimulated insulin secretion
• Triggering and amplifying pathways
• Biphasic insulin release
• Incretin effect (GLP-1, GIP)

Key theories

Triggering and amplifying pathways of glucose-stimulated insulin secretion

Glucose metabolism raises the beta-cell ATP/ADP ratio, closing ATP-sensitive potassium channels, depolarizing the cell, and opening voltage-gated calcium channels (the triggering pathway); a parallel amplifying pathway then augments secretion for a given calcium signal, together shaping the magnitude and time course of insulin release.

Mechanisms

Insulin is synthesized as preproinsulin, cleaved to proinsulin in the endoplasmic reticulum, and processed in secretory granules to mature insulin plus C-peptide, which are co-secreted. Glucose entering the beta cell is metabolized, raising the ATP/ADP ratio; this closes ATP-sensitive potassium channels, depolarizes the membrane, and opens voltage-gated calcium channels, and the resulting calcium influx triggers granule exocytosis. A parallel amplifying (metabolic) pathway enhances the secretory response for a given calcium signal. Secretion is biphasic, with a rapid first phase from a readily releasable granule pool followed by a sustained second phase. Incretin hormones such as GLP-1 and GIP, released from the gut after eating, potentiate glucose-dependent secretion (Henquin, 2000, 2009; Holst, 2007).

Clinical relevance

Defects in insulin secretion are central to diabetes: impaired or lost first-phase secretion and progressive beta-cell failure characterize type 2 diabetes, while autoimmune beta-cell destruction causes type 1 diabetes. C-peptide is used as a marker of endogenous insulin production, and the incretin pathway is a major focus of metabolic research. This entry describes normal secretory physiology and the basis of its failure for educational reference, not for diagnosis or treatment (Prentki & Nolan, 2006; Poitout & Robertson, 2008).

History

Following the isolation of insulin in the 1920s, its precursor proinsulin was discovered in the 1960s, clarifying how the hormone is processed and how C-peptide arises. The mechanism of glucose sensing through ATP-sensitive potassium channels was established in the 1980s, and the distinction between triggering and amplifying pathways was formalized around 2000, refining the model of glucose-stimulated insulin secretion (Henquin, 2000).

Debates

What drives progressive loss of insulin secretion in type 2 diabetes?

Chronic exposure to excess glucose and lipids (glucolipotoxicity), endoplasmic-reticulum stress, and other insults have all been proposed as causes of beta-cell secretory failure; the relative contributions and reversibility of these mechanisms remain debated.

Key figures

• Jean-Claude Henquin
• Jens Juul Holst
• Marc Prentki
• R. Paul Robertson

Seminal works

• henquin-2000
• henquin-2009
• holst-2007

Frequently asked questions

What is C-peptide and why does it matter?

C-peptide is the fragment cleaved from proinsulin when mature insulin is made; because it is released in equal amounts with insulin, it serves as a marker of how much insulin a person's own beta cells are producing.

Why is insulin released in two phases?

An initial rapid first phase reflects release of a readily available pool of insulin granules, followed by a sustained second phase as more granules are mobilized; loss of the first phase is an early sign of beta-cell dysfunction.